B+ FOUNDATION: FUNDING PROGRESS IN CHILDHOOD CANCER RESEARCH WITH ‘BE POSITIVE’ DETERMINATIONThe Andrew McDonough B+ Foundation has supported the Children’s Oncology Group (COG) in so many ways over the years, it’s hard to know where to begin or how to quantify the positive impact it’s had on the world of childhood cancer research. It all started with an outstanding 14-year-old student-athlete with a mop of blond curls, a glowing smile, and a “be positive” attitude.
|
ADVANCING CHILDHOOD KIDNEY CANCER RESEARCH IN EMMA’S MEMORYThe Emma Jordon Kidz Fighting Cancer Foundation started out small, much like the little girl with a big heart who inspired everyone she knew with her fearless spunk and kindness. The Virginia-based foundation has donated more than $120,000 to Children’s Oncology Group research over the last decade, advancing studies on the biology of tumors and paving the way to better treatments and cure rates.
|
Fourth and Gold wins big for pediatric cancer researchIn a few short years, the Fourth and Gold Foundation has given more than $350,000 to support AML, brain tumor, neuroblastoma and ALL research. Erin, the pediatric oncology nurse who launched the foundation, is thrilled – and motivated – to raise even more. Read about the Fourth and Gold game plan scoring big against pediatric cancer.
|
Jeffrey’s Legacy Becomes Larger Than LeukemiaThe Jeffrey Pride Foundation will soon mark 25 years of giving to pediatric cancer research. As they fundraise, they honor the life of their namesake with steadfast hope for more effective treatments. This year, one of several research projects they support is going global and aims to improve outcomes for children with the same rare type of leukemia their friend Jeffrey had.
|
A Young Football Player’s Legacy Helps Science Tackle OsteosarcomaSmart and athletic. Kind and creative. Mason Allen was a kid everyone adored. Five years after his passing, Mason’s legacy was a catalyst for Dr. John Doski’s research into game-changing knowledge in diagnosing, treating and operating on pediatric osteosarcoma patients – the same cancer Mason had.
|